Frequency of rating importance of items/instruments to include in a MCD from 1 (not important) to 9 (very important)
| ITEM | Rate 1–3 | Rate 7–9 | ITEM | Rate 1–3 | Rate 7–9 | ITEM | Rate 1–3 | Rate 7–9 |
|---|---|---|---|---|---|---|---|---|
| Diagnosis of RA | 0% | 100% | Quality of life | 3% | 95% | MSK ultrasound | 22% | 66% |
| Composite Score | 0% | 100% | selected comorbidities | 4% | 93% | BMI | 5% | 65% |
| Tender joint count | 0% | 100% | x-ray hand /feet | 4% | 92% | Occupational therapy | 21% | 64% |
| Swollen joint count | 0% | 100% | NSAIDs | 8% | 90% | Chest-xray | 26% | 63% |
| Patient global | 0% | 99% | Smoking | 0% | 89% | Treatment not related to RA | 22% | 63% |
| Physical function | 1% | 99% | Symptom duration | 7% | 86% | Physiotherapy | 21% | 63% |
| Acute phase reactants | 0% | 99% | Extra-articular manifestation | 6% | 86% | Psychological /Emotional therapy | 19% | 61% |
| Current DMARD | 0% | 99% | Work productivity | 4% | 82% | Physical exercise | 12% | 57% |
| Steroids | 0% | 99% | Joint surgery | 13% | 82% | Grip strength | 21% | 57% |
| Disease duration | 0% | 97% | Fatigue | 3% | 81% | Charlson comorbidity index | 18% | 54% |
| Evaluator global | 0% | 97% | Morning stiffness | 3% | 81% | Podiatry | 29% | 51% |
| Serology | 0% | 97% | Adverse events | 13% | 81% | MRI of joints | 28% | 49% |
| DMARD history | 1% | 97% | Family history | 14% | 79% | Alcohol intake | 7% | 47% |
| Gender | 2% | 96% | Ethnicity | 12% | 69% | Sexual life | 18% | 46% |
| Pain | 1% | 96% | Vaccination | 14% | 68% | Martial status | 41% | 31% |
| Age | 0% | 95% | Socio-economic status | 9% | 67% | Diet | 35% | 27% |